JAK Inhibitors: A Promising Molecular-targeted Therapy in Dermatomyositis

被引：0
|
作者：
Landon-Cardinal, Oceane [1 ]
Guillaume-Jugnot, Perrine [2 ]
Bolko, Lois [2 ]
Toquet, Segolene [2 ]
Rigolet, Aude [2 ]
Hervier, Baptiste [3 ]
Champtiaux, Nicolas [2 ]
Vautier, Mathieu [4 ]
Benveniste, Olivier [5 ]
Allenbach, Yves [5 ]
机构：
[1] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Pitie Salpetriere Univ Hosp, Paris, France
[3] Hop La Pitie Salpetriere, Paris, France
[4] Paris Pitie Salpetriere, Paris, France
[5] Sorbonne Univ, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1280
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Nishida Masatoshi
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (06) : 777 - 779
  • [2] Molecular-targeted therapy in malignant melanoma
    Sullivan, Ryan J.
    Atkins, Michael B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (05) : 567 - 581
  • [3] Cardiotoxicity of Molecular-targeted Drug Therapy
    Le, Duong L.
    Huynh Cao
    Yang, Li-Xi
    ANTICANCER RESEARCH, 2014, 34 (07) : 3243 - 3249
  • [4] Promising newer molecular-targeted therapies in head and neck cancer
    Wang, Lili X.
    Agulnik, Mark
    DRUGS, 2008, 68 (12) : 1609 - 1619
  • [5] Promising Newer Molecular-Targeted Therapies in Head and Neck Cancer
    Lili X. Wang
    Mark Agulnik
    Drugs, 2008, 68 : 1609 - 1619
  • [6] Pneumatosis Intestinalis After Molecular-Targeted Therapy
    Chaudhry, Nauman S.
    Bi, Wenya Linda
    Gupta, Saksham
    Keraliya, Abhishek
    Shimizu, Naomi
    Chiocca, E. Antonio
    WORLD NEUROSURGERY, 2019, 125 : 312 - 315
  • [7] Update on molecular-targeted therapy in hematologic malignancies
    Ueda, Takanori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (05) : 311 - 312
  • [8] Update on molecular-targeted therapy in hematologic malignancies
    Takanori Ueda
    International Journal of Clinical Oncology, 2007, 12 : 311 - 312
  • [9] ROS1 Kinase Inhibitors for Molecular-Targeted Therapies
    Al-Sanea, M. M.
    Abdelazem, A. Z.
    Park, B. S.
    Yoo, K. H.
    Sim, T.
    Kwon, Y. J.
    Lee, S. H.
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (02) : 142 - 160
  • [10] Molecular-Targeted Therapy for Duchenne Muscular DystrophyProgress and Potential
    Anthony Scimè
    Michael A. Rudnicki
    Molecular Diagnosis & Therapy, 2008, 12 : 99 - 108
12345